Imatinib in combination with cytarabine for the treatment of Philadelphia-positive chronic myelogenous leukemia chronic-phase patients: Rationale and design of phase I/II trials
Titel:
Imatinib in combination with cytarabine for the treatment of Philadelphia-positive chronic myelogenous leukemia chronic-phase patients: Rationale and design of phase I/II trials
Auteur:
Guilhot, François Gardembas, Martine Rousselot, Philippe Tulliez, Michel Vigier, Magda Buzyn, Agnès Rigal-Huguet, Françoise Legros, Laurence Michallet, Mauricette Berthou, Christian Najman, Albert Maloisel, Frederic Mahon, François-Xavier Facon, Thierry Berthaud, Patrice Guilhot, Joëlle